Phenominer Database Results (8 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Clinical Measurement Notes Record ID Study ID
BBDR/Rhw percentage of study population developing chronic experimental arthritis during a period of time Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 joint integrity trait male 66 days-126 days 11 100.0 % in vivo visual assessment 0.0 0 69921 1241
BN/SsN percentage of study population developing chronic experimental arthritis during a period of time Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 joint integrity trait female 66 days-126 days 7 0.0 % in vivo visual assessment 0.0 0 69924 1241
BN/SsN percentage of study population developing chronic experimental arthritis during a period of time Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 joint integrity trait male 66 days-126 days 13 0.0 % in vivo visual assessment 0.0 0 69923 1241
BN/SsN calculated serum anti-rat type 2 collagen autoantibody titer Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 blood autoantibody amount male 66 days-126 days 13 1.3 null 0.28 1.0 enzyme linked immunosorbent assay 0.0 0 titer 69927 1241
BBDR/Rhw calculated serum anti-rat type 2 collagen autoantibody titer Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 blood autoantibody amount male 66 days-126 days 11 30.6 null 1.51 5.0 enzyme linked immunosorbent assay 0.0 0 titer 69925 1241
BBDR/Rhw calculated serum anti-rat type 2 collagen autoantibody titer Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 blood autoantibody amount female 66 days-126 days 13 31.7 null 1.75 6.3 enzyme linked immunosorbent assay 0.0 0 titer 69926 1241
BN/SsN calculated serum anti-rat type 2 collagen autoantibody titer Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 blood autoantibody amount female 66 days-126 days 7 1.9 null 0.68 1.8 enzyme linked immunosorbent assay 0.0 0 titer 69928 1241
BBDR/Rhw percentage of study population developing chronic experimental arthritis during a period of time Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 joint integrity trait female 66 days-126 days 13 100.0 % in vivo visual assessment 0.0 0 69922 1241